Cozzi, NV; Frescas, SP; Marona-Lewicka, D; Huang, X; Nichols, DE. Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential Pharmacol. Biochem. Behav., 1 Mar 1998, 59 (3), 709–715. 110 kB. https://doi.org/10.1016/S0091-3057(97)00557-1 #NorFEN
McKenna, DJ; Guan, AM; Shulgin, AT. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine Pharmacol. Biochem. Behav., 1 Jan 1991, 38 (3), 505–12. 783 kB. https://doi.org/10.1016/0091-3057(91)90005-M
Johnson, MP; Nichols, DE. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine Pharmacol. Biochem. Behav., 1 May 1990, 36 (1), 105–109. 521 kB. https://doi.org/10.1016/0091-3057(90)90133-3
Cozzi, NV. Pharmacological studies of some psychoactive phenylalkylamines: entactogens, hallucinogens, and anorectics Ph. D. Thesis, University Of Wisconsin-Madison, 1 Jan 1994. 10.6 MB. #NorFEN LC,MS,NMR
Partilla, JS; Dempsey, AG; Nagpal, AS; Blough, BE; Baumann, MH; Rothman, RB. Interaction of amphetamines and related compounds at the vesicular monoamine transporter J. Pharmacol. Exp. Ther., 1 Oct 2006, 319 (1), 237–246. 367 kB. https://doi.org/10.1124/jpet.106.103622
Kumar, Y; Florvall, L; Ask, AL; Ross, SB; Holm, AC; Ogren, SO. Selective monoamine oxidase inhibitors. Compounds derived from phenethylamine and 1-phenoxy-2-aminopropane Acta Pharm. Suec., 1 Jan 1983, 20 (5), 349–364. 8.1 MB. #14 NMR
Nichols, DE. Medicinal chemistry and structure-activity relationships In Amphetamine and its Analogs; Cho, AK; Segal, DS, Eds., Academic Press, San Diego, CA, 1 Jan 1994; pp 3–41. 8.1 MB.
Biel, JH; Bopp, BA. Amphetamines: Structure-activity relationships In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1 Jan 1978; pp 1–39. 1.0 MB. https://doi.org/10.1007/978-1-4757-0510-2_1
Holland, GF; Buck, CJ; Weissman, A. Anorexigenic agents: Aromatic substituted 1-phenyl-2-propylamines J. Med. Chem., 1 Sep 1963, 6 (5), 519–524. 808 kB. https://doi.org/10.1021/jm00341a011 #3-CF3
Fuller, RW. Structure-activity relationships among the halogenated amphetamines Ann. N. Y. Acad. Sci., 1 Jun 1978, 305 (1), 147–159. 730 kB. https://doi.org/10.1111/j.1749-6632.1978.tb31518.x #Norfenfluramine
Reyes-Parada, M; Iturriaga-Vasquez, P; Cassels, BK. Amphetamine derivatives as monoamine oxidase inhibitors Front. Pharmacol., 23 Jan 2020, 10 1590. 1.9 MB. https://doi.org/10.3389/fphar.2019.01590 #Norfenfluramine